Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
AJANTA PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,426320-   
Low Rs1,062231-   
Sales per share (Unadj.) Rs297.295.1-  
Earnings per share (Unadj.) Rs46.7-24.0-  
Cash flow per share (Unadj.) Rs57.1-19.9-  
Dividends per share (Unadj.) Rs7.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs269.174.6-  
Shares outstanding (eoy) m125.91168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.22.9 144.6%   
Avg P/E ratio x26.6-11.5 -232.0%  
P/CF ratio (eoy) x21.8-13.9 -157.3%  
Price / Book Value ratio x4.63.7 125.4%  
Dividend payout %15.00-   
Avg Mkt Cap Rs m156,63846,446 337.3%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m7,8512,915 269.3%   
Avg. sales/employee Rs Th03,739.2-  
Avg. wages/employee Rs Th0679.0-  
Avg. net profit/employee Rs Th0-942.2-  
INCOME DATA
Net Sales Rs m37,42616,052 233.2%  
Other income Rs m986112 877.5%   
Total revenues Rs m38,41316,165 237.6%   
Gross profit Rs m7,833-2,782 -281.6%  
Depreciation Rs m1,308693 188.8%   
Interest Rs m58435 13.4%   
Profit before tax Rs m7,453-3,797 -196.3%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,573237 662.9%   
Profit after tax Rs m5,880-4,045 -145.4%  
Gross profit margin %20.9-17.3 -120.8%  
Effective tax rate %21.1-6.2 -337.7%   
Net profit margin %15.7-25.2 -62.3%  
BALANCE SHEET DATA
Current assets Rs m28,25211,757 240.3%   
Current liabilities Rs m11,3936,615 172.2%   
Net working cap to sales %45.032.0 140.6%  
Current ratio x2.51.8 139.5%  
Inventory Days Days66111 59.4%  
Debtors Days Days10124 8.3%  
Net fixed assets Rs m18,7076,853 273.0%   
Share capital Rs m25375 339.1%   
"Free" reserves Rs m33,6240-   
Net worth Rs m33,87712,599 268.9%   
Long term debt Rs m134,428 0.3%   
Total assets Rs m47,04723,801 197.7%  
Interest coverage x128.6-7.7 -1,663.3%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x0.80.7 118.0%   
Return on assets %12.6-15.2 -83.2%  
Return on equity %17.4-32.1 -54.1%  
Return on capital %22.2-19.8 -111.9%  
Exports to sales %59.90-   
Imports to sales %11.50-   
Net fx Rs m18,1270-   
CASH FLOW
From Operations Rs m7,9181,370 577.9%  
From Investments Rs m-5,596-421 1,330.1%  
From Financial Activity Rs m-1,0794,018 -26.8%  
Net Cashflow Rs m1,2434,968 25.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.41 Rs / ZAR

Compare AJANTA PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare AJANTA PHARMA With: ISTREET NETWORK  LAURUS LABS   GODAVARI DRU  NATCO PHARMA  SOLARA ACTIVE PHARMA SCIENCES  



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.